← Eichor
Condition: Adalimumab Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Adalimumab

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects
Phase 1 · 1 location(s) · Prestige Biopharma Limited · NCT05108259Pre-treatment With Azithromycin to Reduce Immunogenicity to to Anti-TNF Agents in Patients With Crohn's Disease
Phase 2 · 9 location(s) · Rambam Health Care Campus · NCT05599347A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Phase 4 · 53 location(s) · Takeda · NCT06045754Biologics and Paediatric Enteral Nutrition in Crohn's Disease Study
NA · 6 location(s) · University of Glasgow · NCT07522528Swiss Dermatology Network of Targeted Therapies (SDNTT)
Phase N/A · 6 location(s) · Swiss Dermatology Network for Targeted Therapies · NCT01706692Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
Phase 4 · 1 location(s) · Fundación de Investigación Biomédica - Hospital Universitari · NCT05313620Control Crohn Safe Trial
Phase 4 · 6 location(s) · Maastricht University Medical Center · NCT03917303A Pilot Study in Severe Patients With Takayasu Arteritis.
Phase 4 · 1 location(s) · Shanghai Zhongshan Hospital · NCT04300686A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With J
Phase 3 · 33 location(s) · AbbVie · NCT06100744A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With S
Phase 4 · 1 location(s) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07663331Baricitinib in the Treatment of Intestinal Behçet's Syndrome
Phase 2 · 2 location(s) · Peking Union Medical College Hospital · NCT06849908TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response
Phase 4 · 1 location(s) · Sixth Affiliated Hospital, Sun Yat-sen University · NCT07510191A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New On
Phase 1/Phase 2 · 11 location(s) · City of Hope Medical Center · NCT07061574A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulc
Phase 4 · 24 location(s) · Groupe d'Etude Therapeutique des Affections Inflammatoires D · NCT04183608Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response
Phase 4 · 12 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06180382Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Rand
Phase 3 · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05040464Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
Phase N/A · 10 location(s) · Medical University Innsbruck · NCT06954311Adebrelimab Combined With Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Phase 2 · 1 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT07595770Design and Evaluation of an Individualized Biodrug Tapering Strategy Based on Biodrug Dosage: the MONITORA Study
Phase 4 · 8 location(s) · Centre Hospitalier Universitaire de Saint Etienne · NCT06528431Evaluation of IL 12B Genetic Polymorphism (rs3213094)
NA · 1 location(s) · South Valley University · NCT07128472Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
Phase 4 · 1 location(s) · Psoriasis Treatment Center of Central New Jersey · NCT03827876A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease
Phase N/A · 1 location(s) · Tianjin Medical University · NCT05590416Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
Phase 2 · 1 location(s) · Tom Appleton · NCT06037811Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
Phase 2 · 1 location(s) · American University of Beirut Medical Center · NCT02706704
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.